Biomet has filed to raise up to $100M in an IPO seven years after being taken private for $11.4B. The final size of the offering will probably be higher, with Reuters previously reporting that the firm could look to raise over $1B.
The medical-device maker didn't say how many shares it would sell, nor the exchange it would list on, although it did say it would trade under the ticker symbol BMET.
The company's products include dental implants and artificial hip joints, and it competes with Smith & Nephew and Stryker.
Biomet's main owners are Blackstone (BX), KKR (KKR), Goldman Sach's (GS) P-E arm, and TPG Capital.